➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Moodys
McKinsey
Merck
Baxter
Colorcon

Last Updated: September 29, 2020

DrugPatentWatch Database Preview

Patent: 7,593,397

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,593,397
Title:Method for securing communication in a local area network switch
Abstract: Method for securing communication in a local area network switch (AN) comprising a user interface (UI) and a network interface (NI), comprises the steps of extracting a source address (MACi) from each packet received by said Local area network switch (AN) and storing said address (MACi) together with associated information into a address forwarding table (FT) comprised in said Local area network switch (AN) is characterised in that a distinction is made between source addresses received from the user interface (UI) and the network interface (NI), such that upon detecting that a source address (MACi) contained within a newly received packet at the user interface (UI) was already stored as a source address received at the network interface (NI), said newly received packet will be discarded and its source address contained therein will not be stored within said address forwarding table (FT).
Inventor(s): De Cnodder; Stefaan Jozef (Lille, BE), Mensch; Patrick Paul Yvonne (Edegem, BE)
Assignee: Alcatel (Paris, FR)
Application Number:11/177,313
Patent Claims:see list of patent claims

Details for Patent 7,593,397

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Vericel Corporation MACI autologous cultured chondrocytes IMPLANT 125603 001 2017-01-11   Start Trial Alcatel (Paris, FR) 2024-07-16 search
Vericel Corporation MACI autologous cultured chondrocytes IMPLANT 125603 1 2017-01-11   Start Trial Alcatel (Paris, FR) 2024-07-16 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Johnson and Johnson
Mallinckrodt
Express Scripts
Harvard Business School
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.